Published in:
Open Access
01-12-2011 | Research article
Osteopontin, asbestos exposure and pleural plaques: a cross-sectional study
Authors:
Giuseppe Mastrangelo, Gianluca Marangi, Maria N Ballarin, Silvia Michilin, Aline SC Fabricio, Flavio Valentini, John H Lange, Ugo Fedeli, Luca Cegolon, Massimo Gion
Published in:
BMC Public Health
|
Issue 1/2011
Login to get access
Abstract
Background
Osteopontin (OPN) is a plasma protein/cytokine produced in excess in several malignancies. In a recent study OPN was reported as being related to the duration of asbestos exposure and presence of benign asbestos-related diseases; however, it was unclear whether this protein was an indicator of exposure or effect.
Methods
In 193 workers, 50 with pleural plaques (PP), in whom different indicators of past asbestos exposure were estimated, OPN plasma levels were assessed using commercial quantitative sandwich enzyme immunoassays according to the manufacturer's instructions.
Results
Osteopontin increased with increasing age and several aspects of asbestos exposure, without differences related to the presence of pleural plaques. At multivariable regression analysis, the explanatory variables with a significant independent influence on OPN were length of exposure (positive correlation) and time elapsed since last exposure (positive correlation).
Conclusions
Since asbestos in lung tissue tends to wane over time, OPN should decrease (rather than increase) with time since last exposure. Therefore, OPN cannot be a reliable biomarker of exposure nor effect (presence of pleural plaques).